Exalt Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.50 M
- Revenue Growth -46.83%
- Profit Growth -29.24%
- Ebitda -28.49%
- Net Worth 10.62%
- Total Assets -11.63%
About Exalt Pharmaceuticals
Exalt Pharmaceuticals Private Limited (EPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 November 2014 and has a history of Ten years and five months. Its registered office is in Faridabad, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.50 M.
Bhola Gupta and Veena Gupta serve as directors at the Company.
Company Details
- Location
Faridabad, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24100HR2014PTC053831
- Company No.
053831
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Exalt Pharmaceuticals Private Limited
Explore comprehensive data for Exalt Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Exalt Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhola Gupta  | Director | 24-Nov-2014 | Current |
| Veena Gupta | Director | 24-Nov-2014 | Current |
Financial Performance of Exalt Pharmaceuticals.
Exalt Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 46.83% decrease. The company also saw a substantial fall in profitability, with a 29.24% decrease in profit. The company's net worth Soared by an impressive increase of 10.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exalt Pharmaceuticals?
Unlock access to Exalt Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Ortal Fashion Private Limited
Bhola Gupta and Veena Gupta are mutual person
- Panacea Multicon Private Limited
Bhola Gupta and Veena Gupta are mutual person
- Gargill Infrastructure Private Limited
Bhola Gupta and Veena Gupta are mutual person
- Panacea Buildpro Private Limited
Bhola Gupta is a mutual person
- Novotel Pharmaceuticals Private Limited
Bhola Gupta and Veena Gupta are mutual person
- Glato Foodgrains Private Limited
Bhola Gupta and Veena Gupta are mutual person
Charges (Loans)
Open Charges
₹7.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2015 | Canara Bank | ₹7.50 M | Open |
How Many Employees Work at Exalt Pharmaceuticals?
Unlock and access historical data on people associated with Exalt Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exalt Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exalt Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Exalt Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Exalt Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Exalt Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Canara Bank amounted to Rs. 7.50 M with Charge ID 10566590 was registered on 11 Mar 2015.
- Director Appointment
Bhola Nath Prasad Gupta was appointed as a Director was appointed as a Director on 24 Nov 2014 & has been associated with this company since 10 years 5 months .
- Director Appointment
Veena Gupta was appointed as a Director was appointed as a Director on 24 Nov 2014 & has been associated with this company since 10 years 5 months .
- Company Incorporation
Exalt Pharmaceuticals Private Limited was registered on 24 Nov 2014 with Roc Delhi & aged 10 years 5 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Exalt Pharmaceuticals Private Limited?
Exalt Pharmaceuticals Private Limited was incorporated on 24 Nov 2014.
What is authorized share capital and paid-up capital of Exalt Pharmaceuticals Private Limited?
The authorized share capital of Exalt Pharmaceuticals Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.
Who are the current board members & directors of Exalt Pharmaceuticals Private Limited?
Currently 2 directors are associated with Exalt Pharmaceuticals Private Limited.
- Bhola Nath Prasad Gupta
- Veena Gupta
What is the registered address of Exalt Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Exalt Pharmaceuticals Private Limited is 1207A Sector-37 India, Faridabad, Haryana, 121003.
What is the corporate identification number (CIN) and company number of Exalt Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Exalt Pharmaceuticals Private Limited is U24100HR2014PTC053831 and the company number is 053831 as per Ministry of Corporate Affairs (MCA).
What is the official website of Exalt Pharmaceuticals Private Limited?
The Official website of Exalt Pharmaceuticals Private Limited is https://www.exaltpharmaceuticals.com
What has been the recent revenue trend for Exalt Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Exalt Pharmaceuticals Private Limited has fallen by -46.83%.
What change has been observed in the net worth of Exalt Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Exalt Pharmaceuticals Private Limited has experienced an upsurge of 10.62%.
What are the total open charges for Exalt Pharmaceuticals Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Exalt Pharmaceuticals Private Limited amount to ₹ 7.50 M.
When was the last Balance Sheet of Exalt Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Exalt Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records